CERo Therapeutics Holdings Inc

Insider buying surge at CERo Therapeutics signals CEO confidence amid steep stock drop and limited funding; watch Phase‑1 data, FDA moves and liquidity risks before investing.

Insider buying of 9.6 M CERo stock options signals confidence amid a volatile biotech market; analysts weigh clinical milestones, FDA approvals, and social buzz for upside potential.